Botulinum Neurotoxins-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Botulinum Neurotoxins-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Botulinum Neurotoxins industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Botulinum Neurotoxins 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Botulinum Neurotoxins worldwide and market share by regions, with company and product introduction, position in the Botulinum Neurotoxins market
Market status and development trend of Botulinum Neurotoxins by types and applications
Cost and profit status of Botulinum Neurotoxins, and marketing status
Market growth drivers and challenges
The report segments the global Botulinum Neurotoxins market as:
Global Botulinum Neurotoxins Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Botulinum Neurotoxins Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
Global Botulinum Neurotoxins Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Uses
Cosmetics
Global Botulinum Neurotoxins Market: Manufacturers Segment Analysis (Company and Product introduction, Botulinum Neurotoxins Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Botulinum Neurotoxins-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Botulinum Neurotoxins industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Botulinum Neurotoxins 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Botulinum Neurotoxins worldwide and market share by regions, with company and product introduction, position in the Botulinum Neurotoxins market
Market status and development trend of Botulinum Neurotoxins by types and applications
Cost and profit status of Botulinum Neurotoxins, and marketing status
Market growth drivers and challenges
The report segments the global Botulinum Neurotoxins market as:
Global Botulinum Neurotoxins Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Botulinum Neurotoxins Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Botulinum Neurotoxins A (BoNT/A)
Botulinum Neurotoxins B (BoNT/B)
Botulinum Neurotoxins E (BoNT/E)
Botulinum Neurotoxins F (BoNT/F)
Botulinum Neurotoxins C (BoNT/C)
Botulinum Neurotoxins D (BoNT/D)
Botulinum Neurotoxins G (BoNT/G)
Global Botulinum Neurotoxins Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Medical Uses
Cosmetics
Global Botulinum Neurotoxins Market: Manufacturers Segment Analysis (Company and Product introduction, Botulinum Neurotoxins Sales Volume, Revenue, Price and Gross Margin):
Johnson & Johnson
GSK
Allergan
Chong Kun Dang
Eisai
Nestle
Galderma
Ipsen
Hugel
Mentor
CROMA
Alphaeon
OBI Pharma
Revance Therapeutics
Daewoong Pharmaceutical
Medy-Tox
EpiVax
Anterios
Escape Therapeutics
Lipella
Malvern Cosmeceutics
PharmaVital
Merz Pharma
Transdermal
Valeant Pharmaceuticals
CNBG
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BOTULINUM NEUROTOXINS
1.1 Definition of Botulinum Neurotoxins in This Report
1.2 Commercial Types of Botulinum Neurotoxins
1.2.1 Botulinum Neurotoxins A (BoNT/A)
1.2.2 Botulinum Neurotoxins B (BoNT/B)
1.2.3 Botulinum Neurotoxins E (BoNT/E)
1.2.4 Botulinum Neurotoxins F (BoNT/F)
1.2.5 Botulinum Neurotoxins C (BoNT/C)
1.2.6 Botulinum Neurotoxins D (BoNT/D)
1.2.7 Botulinum Neurotoxins G (BoNT/G)
1.3 Downstream Application of Botulinum Neurotoxins
1.3.1 Medical Uses
1.3.2 Cosmetics
1.4 Development History of Botulinum Neurotoxins
1.5 Market Status and Trend of Botulinum Neurotoxins 2013-2023
1.5.1 Global Botulinum Neurotoxins Market Status and Trend 2013-2023
1.5.2 Regional Botulinum Neurotoxins Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Botulinum Neurotoxins 2013-2017
2.2 Sales Market of Botulinum Neurotoxins by Regions
2.2.1 Sales Volume of Botulinum Neurotoxins by Regions
2.2.2 Sales Value of Botulinum Neurotoxins by Regions
2.3 Production Market of Botulinum Neurotoxins by Regions
2.4 Global Market Forecast of Botulinum Neurotoxins 2018-2023
2.4.1 Global Market Forecast of Botulinum Neurotoxins 2018-2023
2.4.2 Market Forecast of Botulinum Neurotoxins by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Botulinum Neurotoxins by Types
3.2 Sales Value of Botulinum Neurotoxins by Types
3.3 Market Forecast of Botulinum Neurotoxins by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Botulinum Neurotoxins by Downstream Industry
4.2 Global Market Forecast of Botulinum Neurotoxins by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Botulinum Neurotoxins Market Status by Countries
5.1.1 North America Botulinum Neurotoxins Sales by Countries (2013-2017)
5.1.2 North America Botulinum Neurotoxins Revenue by Countries (2013-2017)
5.1.3 United States Botulinum Neurotoxins Market Status (2013-2017)
5.1.4 Canada Botulinum Neurotoxins Market Status (2013-2017)
5.1.5 Mexico Botulinum Neurotoxins Market Status (2013-2017)
5.2 North America Botulinum Neurotoxins Market Status by Manufacturers
5.3 North America Botulinum Neurotoxins Market Status by Type (2013-2017)
5.3.1 North America Botulinum Neurotoxins Sales by Type (2013-2017)
5.3.2 North America Botulinum Neurotoxins Revenue by Type (2013-2017)
5.4 North America Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Botulinum Neurotoxins Market Status by Countries
6.1.1 Europe Botulinum Neurotoxins Sales by Countries (2013-2017)
6.1.2 Europe Botulinum Neurotoxins Revenue by Countries (2013-2017)
6.1.3 Germany Botulinum Neurotoxins Market Status (2013-2017)
6.1.4 UK Botulinum Neurotoxins Market Status (2013-2017)
6.1.5 France Botulinum Neurotoxins Market Status (2013-2017)
6.1.6 Italy Botulinum Neurotoxins Market Status (2013-2017)
6.1.7 Russia Botulinum Neurotoxins Market Status (2013-2017)
6.1.8 Spain Botulinum Neurotoxins Market Status (2013-2017)
6.1.9 Benelux Botulinum Neurotoxins Market Status (2013-2017)
6.2 Europe Botulinum Neurotoxins Market Status by Manufacturers
6.3 Europe Botulinum Neurotoxins Market Status by Type (2013-2017)
6.3.1 Europe Botulinum Neurotoxins Sales by Type (2013-2017)
6.3.2 Europe Botulinum Neurotoxins Revenue by Type (2013-2017)
6.4 Europe Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Botulinum Neurotoxins Market Status by Countries
7.1.1 Asia Pacific Botulinum Neurotoxins Sales by Countries (2013-2017)
7.1.2 Asia Pacific Botulinum Neurotoxins Revenue by Countries (2013-2017)
7.1.3 China Botulinum Neurotoxins Market Status (2013-2017)
7.1.4 Japan Botulinum Neurotoxins Market Status (2013-2017)
7.1.5 India Botulinum Neurotoxins Market Status (2013-2017)
7.1.6 Southeast Asia Botulinum Neurotoxins Market Status (2013-2017)
7.1.7 Australia Botulinum Neurotoxins Market Status (2013-2017)
7.2 Asia Pacific Botulinum Neurotoxins Market Status by Manufacturers
7.3 Asia Pacific Botulinum Neurotoxins Market Status by Type (2013-2017)
7.3.1 Asia Pacific Botulinum Neurotoxins Sales by Type (2013-2017)
7.3.2 Asia Pacific Botulinum Neurotoxins Revenue by Type (2013-2017)
7.4 Asia Pacific Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Botulinum Neurotoxins Market Status by Countries
8.1.1 Latin America Botulinum Neurotoxins Sales by Countries (2013-2017)
8.1.2 Latin America Botulinum Neurotoxins Revenue by Countries (2013-2017)
8.1.3 Brazil Botulinum Neurotoxins Market Status (2013-2017)
8.1.4 Argentina Botulinum Neurotoxins Market Status (2013-2017)
8.1.5 Colombia Botulinum Neurotoxins Market Status (2013-2017)
8.2 Latin America Botulinum Neurotoxins Market Status by Manufacturers
8.3 Latin America Botulinum Neurotoxins Market Status by Type (2013-2017)
8.3.1 Latin America Botulinum Neurotoxins Sales by Type (2013-2017)
8.3.2 Latin America Botulinum Neurotoxins Revenue by Type (2013-2017)
8.4 Latin America Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Botulinum Neurotoxins Market Status by Countries
9.1.1 Middle East and Africa Botulinum Neurotoxins Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Botulinum Neurotoxins Revenue by Countries (2013-2017)
9.1.3 Middle East Botulinum Neurotoxins Market Status (2013-2017)
9.1.4 Africa Botulinum Neurotoxins Market Status (2013-2017)
9.2 Middle East and Africa Botulinum Neurotoxins Market Status by Manufacturers
9.3 Middle East and Africa Botulinum Neurotoxins Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Botulinum Neurotoxins Sales by Type (2013-2017)
9.3.2 Middle East and Africa Botulinum Neurotoxins Revenue by Type (2013-2017)
9.4 Middle East and Africa Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BOTULINUM NEUROTOXINS
10.1 Global Economy Situation and Trend Overview
10.2 Botulinum Neurotoxins Downstream Industry Situation and Trend Overview
CHAPTER 11 BOTULINUM NEUROTOXINS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Botulinum Neurotoxins by Major Manufacturers
11.2 Production Value of Botulinum Neurotoxins by Major Manufacturers
11.3 Basic Information of Botulinum Neurotoxins by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Botulinum Neurotoxins Major Manufacturer
11.3.2 Employees and Revenue Level of Botulinum Neurotoxins Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BOTULINUM NEUROTOXINS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Botulinum Neurotoxins Product
12.1.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 GSK
12.2.1 Company profile
12.2.2 Representative Botulinum Neurotoxins Product
12.2.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of GSK
12.3 Allergan
12.3.1 Company profile
12.3.2 Representative Botulinum Neurotoxins Product
12.3.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Allergan
12.4 Chong Kun Dang
12.4.1 Company profile
12.4.2 Representative Botulinum Neurotoxins Product
12.4.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Chong Kun Dang
12.5 Eisai
12.5.1 Company profile
12.5.2 Representative Botulinum Neurotoxins Product
12.5.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Eisai
12.6 Nestle
12.6.1 Company profile
12.6.2 Representative Botulinum Neurotoxins Product
12.6.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Nestle
12.7 Galderma
12.7.1 Company profile
12.7.2 Representative Botulinum Neurotoxins Product
12.7.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Galderma
12.8 Ipsen
12.8.1 Company profile
12.8.2 Representative Botulinum Neurotoxins Product
12.8.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Ipsen
12.9 Hugel
12.9.1 Company profile
12.9.2 Representative Botulinum Neurotoxins Product
12.9.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Hugel
12.10 Mentor
12.10.1 Company profile
12.10.2 Representative Botulinum Neurotoxins Product
12.10.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Mentor
12.11 CROMA
12.11.1 Company profile
12.11.2 Representative Botulinum Neurotoxins Product
12.11.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of CROMA
12.12 Alphaeon
12.12.1 Company profile
12.12.2 Representative Botulinum Neurotoxins Product
12.12.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Alphaeon
12.13 OBI Pharma
12.13.1 Company profile
12.13.2 Representative Botulinum Neurotoxins Product
12.13.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of OBI Pharma
12.14 Revance Therapeutics
12.14.1 Company profile
12.14.2 Representative Botulinum Neurotoxins Product
12.14.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Revance Therapeutics
12.15 Daewoong Pharmaceutical
12.15.1 Company profile
12.15.2 Representative Botulinum Neurotoxins Product
12.15.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Daewoong Pharmaceutical
12.16 Medy-Tox
12.17 EpiVax
12.18 Anterios
12.19 Escape Therapeutics
12.20 Lipella
12.21 Malvern Cosmeceutics
12.22 PharmaVital
12.23 Merz Pharma
12.24 Transdermal
12.25 Valeant Pharmaceuticals
12.26 CNBG
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BOTULINUM NEUROTOXINS
13.1 Industry Chain of Botulinum Neurotoxins
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BOTULINUM NEUROTOXINS
14.1 Cost Structure Analysis of Botulinum Neurotoxins
14.2 Raw Materials Cost Analysis of Botulinum Neurotoxins
14.3 Labor Cost Analysis of Botulinum Neurotoxins
14.4 Manufacturing Expenses Analysis of Botulinum Neurotoxins
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Botulinum Neurotoxins in This Report
1.2 Commercial Types of Botulinum Neurotoxins
1.2.1 Botulinum Neurotoxins A (BoNT/A)
1.2.2 Botulinum Neurotoxins B (BoNT/B)
1.2.3 Botulinum Neurotoxins E (BoNT/E)
1.2.4 Botulinum Neurotoxins F (BoNT/F)
1.2.5 Botulinum Neurotoxins C (BoNT/C)
1.2.6 Botulinum Neurotoxins D (BoNT/D)
1.2.7 Botulinum Neurotoxins G (BoNT/G)
1.3 Downstream Application of Botulinum Neurotoxins
1.3.1 Medical Uses
1.3.2 Cosmetics
1.4 Development History of Botulinum Neurotoxins
1.5 Market Status and Trend of Botulinum Neurotoxins 2013-2023
1.5.1 Global Botulinum Neurotoxins Market Status and Trend 2013-2023
1.5.2 Regional Botulinum Neurotoxins Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Botulinum Neurotoxins 2013-2017
2.2 Sales Market of Botulinum Neurotoxins by Regions
2.2.1 Sales Volume of Botulinum Neurotoxins by Regions
2.2.2 Sales Value of Botulinum Neurotoxins by Regions
2.3 Production Market of Botulinum Neurotoxins by Regions
2.4 Global Market Forecast of Botulinum Neurotoxins 2018-2023
2.4.1 Global Market Forecast of Botulinum Neurotoxins 2018-2023
2.4.2 Market Forecast of Botulinum Neurotoxins by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Botulinum Neurotoxins by Types
3.2 Sales Value of Botulinum Neurotoxins by Types
3.3 Market Forecast of Botulinum Neurotoxins by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Botulinum Neurotoxins by Downstream Industry
4.2 Global Market Forecast of Botulinum Neurotoxins by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Botulinum Neurotoxins Market Status by Countries
5.1.1 North America Botulinum Neurotoxins Sales by Countries (2013-2017)
5.1.2 North America Botulinum Neurotoxins Revenue by Countries (2013-2017)
5.1.3 United States Botulinum Neurotoxins Market Status (2013-2017)
5.1.4 Canada Botulinum Neurotoxins Market Status (2013-2017)
5.1.5 Mexico Botulinum Neurotoxins Market Status (2013-2017)
5.2 North America Botulinum Neurotoxins Market Status by Manufacturers
5.3 North America Botulinum Neurotoxins Market Status by Type (2013-2017)
5.3.1 North America Botulinum Neurotoxins Sales by Type (2013-2017)
5.3.2 North America Botulinum Neurotoxins Revenue by Type (2013-2017)
5.4 North America Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Botulinum Neurotoxins Market Status by Countries
6.1.1 Europe Botulinum Neurotoxins Sales by Countries (2013-2017)
6.1.2 Europe Botulinum Neurotoxins Revenue by Countries (2013-2017)
6.1.3 Germany Botulinum Neurotoxins Market Status (2013-2017)
6.1.4 UK Botulinum Neurotoxins Market Status (2013-2017)
6.1.5 France Botulinum Neurotoxins Market Status (2013-2017)
6.1.6 Italy Botulinum Neurotoxins Market Status (2013-2017)
6.1.7 Russia Botulinum Neurotoxins Market Status (2013-2017)
6.1.8 Spain Botulinum Neurotoxins Market Status (2013-2017)
6.1.9 Benelux Botulinum Neurotoxins Market Status (2013-2017)
6.2 Europe Botulinum Neurotoxins Market Status by Manufacturers
6.3 Europe Botulinum Neurotoxins Market Status by Type (2013-2017)
6.3.1 Europe Botulinum Neurotoxins Sales by Type (2013-2017)
6.3.2 Europe Botulinum Neurotoxins Revenue by Type (2013-2017)
6.4 Europe Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Botulinum Neurotoxins Market Status by Countries
7.1.1 Asia Pacific Botulinum Neurotoxins Sales by Countries (2013-2017)
7.1.2 Asia Pacific Botulinum Neurotoxins Revenue by Countries (2013-2017)
7.1.3 China Botulinum Neurotoxins Market Status (2013-2017)
7.1.4 Japan Botulinum Neurotoxins Market Status (2013-2017)
7.1.5 India Botulinum Neurotoxins Market Status (2013-2017)
7.1.6 Southeast Asia Botulinum Neurotoxins Market Status (2013-2017)
7.1.7 Australia Botulinum Neurotoxins Market Status (2013-2017)
7.2 Asia Pacific Botulinum Neurotoxins Market Status by Manufacturers
7.3 Asia Pacific Botulinum Neurotoxins Market Status by Type (2013-2017)
7.3.1 Asia Pacific Botulinum Neurotoxins Sales by Type (2013-2017)
7.3.2 Asia Pacific Botulinum Neurotoxins Revenue by Type (2013-2017)
7.4 Asia Pacific Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Botulinum Neurotoxins Market Status by Countries
8.1.1 Latin America Botulinum Neurotoxins Sales by Countries (2013-2017)
8.1.2 Latin America Botulinum Neurotoxins Revenue by Countries (2013-2017)
8.1.3 Brazil Botulinum Neurotoxins Market Status (2013-2017)
8.1.4 Argentina Botulinum Neurotoxins Market Status (2013-2017)
8.1.5 Colombia Botulinum Neurotoxins Market Status (2013-2017)
8.2 Latin America Botulinum Neurotoxins Market Status by Manufacturers
8.3 Latin America Botulinum Neurotoxins Market Status by Type (2013-2017)
8.3.1 Latin America Botulinum Neurotoxins Sales by Type (2013-2017)
8.3.2 Latin America Botulinum Neurotoxins Revenue by Type (2013-2017)
8.4 Latin America Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Botulinum Neurotoxins Market Status by Countries
9.1.1 Middle East and Africa Botulinum Neurotoxins Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Botulinum Neurotoxins Revenue by Countries (2013-2017)
9.1.3 Middle East Botulinum Neurotoxins Market Status (2013-2017)
9.1.4 Africa Botulinum Neurotoxins Market Status (2013-2017)
9.2 Middle East and Africa Botulinum Neurotoxins Market Status by Manufacturers
9.3 Middle East and Africa Botulinum Neurotoxins Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Botulinum Neurotoxins Sales by Type (2013-2017)
9.3.2 Middle East and Africa Botulinum Neurotoxins Revenue by Type (2013-2017)
9.4 Middle East and Africa Botulinum Neurotoxins Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF BOTULINUM NEUROTOXINS
10.1 Global Economy Situation and Trend Overview
10.2 Botulinum Neurotoxins Downstream Industry Situation and Trend Overview
CHAPTER 11 BOTULINUM NEUROTOXINS MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Botulinum Neurotoxins by Major Manufacturers
11.2 Production Value of Botulinum Neurotoxins by Major Manufacturers
11.3 Basic Information of Botulinum Neurotoxins by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Botulinum Neurotoxins Major Manufacturer
11.3.2 Employees and Revenue Level of Botulinum Neurotoxins Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 BOTULINUM NEUROTOXINS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Johnson & Johnson
12.1.1 Company profile
12.1.2 Representative Botulinum Neurotoxins Product
12.1.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Johnson & Johnson
12.2 GSK
12.2.1 Company profile
12.2.2 Representative Botulinum Neurotoxins Product
12.2.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of GSK
12.3 Allergan
12.3.1 Company profile
12.3.2 Representative Botulinum Neurotoxins Product
12.3.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Allergan
12.4 Chong Kun Dang
12.4.1 Company profile
12.4.2 Representative Botulinum Neurotoxins Product
12.4.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Chong Kun Dang
12.5 Eisai
12.5.1 Company profile
12.5.2 Representative Botulinum Neurotoxins Product
12.5.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Eisai
12.6 Nestle
12.6.1 Company profile
12.6.2 Representative Botulinum Neurotoxins Product
12.6.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Nestle
12.7 Galderma
12.7.1 Company profile
12.7.2 Representative Botulinum Neurotoxins Product
12.7.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Galderma
12.8 Ipsen
12.8.1 Company profile
12.8.2 Representative Botulinum Neurotoxins Product
12.8.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Ipsen
12.9 Hugel
12.9.1 Company profile
12.9.2 Representative Botulinum Neurotoxins Product
12.9.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Hugel
12.10 Mentor
12.10.1 Company profile
12.10.2 Representative Botulinum Neurotoxins Product
12.10.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Mentor
12.11 CROMA
12.11.1 Company profile
12.11.2 Representative Botulinum Neurotoxins Product
12.11.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of CROMA
12.12 Alphaeon
12.12.1 Company profile
12.12.2 Representative Botulinum Neurotoxins Product
12.12.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Alphaeon
12.13 OBI Pharma
12.13.1 Company profile
12.13.2 Representative Botulinum Neurotoxins Product
12.13.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of OBI Pharma
12.14 Revance Therapeutics
12.14.1 Company profile
12.14.2 Representative Botulinum Neurotoxins Product
12.14.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Revance Therapeutics
12.15 Daewoong Pharmaceutical
12.15.1 Company profile
12.15.2 Representative Botulinum Neurotoxins Product
12.15.3 Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin of Daewoong Pharmaceutical
12.16 Medy-Tox
12.17 EpiVax
12.18 Anterios
12.19 Escape Therapeutics
12.20 Lipella
12.21 Malvern Cosmeceutics
12.22 PharmaVital
12.23 Merz Pharma
12.24 Transdermal
12.25 Valeant Pharmaceuticals
12.26 CNBG
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BOTULINUM NEUROTOXINS
13.1 Industry Chain of Botulinum Neurotoxins
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF BOTULINUM NEUROTOXINS
14.1 Cost Structure Analysis of Botulinum Neurotoxins
14.2 Raw Materials Cost Analysis of Botulinum Neurotoxins
14.3 Labor Cost Analysis of Botulinum Neurotoxins
14.4 Manufacturing Expenses Analysis of Botulinum Neurotoxins
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
